News Nemaura Medical Inc.

Equities

NMRD

US6404422080

Market Closed - OTC Markets Other stock markets 03:19:01 2024-04-23 pm EDT			5-day change	1st Jan Change
0.06 ^USD	-16.67%		-19.03%	-72.60%

Apr. 10	Nemaura Medical Inc. Announces Board Changes	CI
Feb. 12	Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nemaura Medical : Certificate of Incorporation/Bylaws - Form 8-K	Apr. 22	PU
Nemaura Medical Inc. Announces Board Changes	Apr. 10	CI
Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Nemaura Medical Inc.(OTCPK:NMRD) dropped from S&P TMI Index	Jan. 09	CI
Nemaura Medical Inc. - Important Update on Listing Status and Strategic Direction	Jan. 04	AQ
Nemaura Medical Inc.(OTCPK:NMRD) dropped from NASDAQ Composite Index	Jan. 04	CI
Important Update on Listing Status and Strategic Direction	Jan. 03	AQ
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision	Dec. 13	AQ
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth	Nov. 21	AQ
Nemaura Medical Rolls Out Metabolic Health Program in UK	Nov. 14	MT
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	Nov. 14	AQ
Nemaura Medical Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	Nov. 14	CI
Nemaura Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13	CI
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update	Nov. 13	AQ
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.	23-09-26	AQ
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference	23-09-18	AQ
Nemaura Medical Says Nasdaq Listing Standards Probably Won't Be Met by Deadline	23-09-14	MT
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process	23-09-14	AQ
Top Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)	23-09-14	AQ
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program	23-09-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nemaura Medical Inc.

Equities

NMRD

US6404422080

Summary

Filters